Magus Biotechnology Corp.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
1. One-Stop Botanical Drug Development
2. Active Ingredient Development of Chinese Herbal Medicines
3. Functional Evaluation
4. GACP Technical Services
5. Development of Classical Chinese Medicine Formulas
6. Post-Marketing Research of Proprietary Chinese Medicines
7. Core Facility Platform Services
(The content above was translated by AI.)
2. Active Ingredient Development of Chinese Herbal Medicines
3. Functional Evaluation
4. GACP Technical Services
5. Development of Classical Chinese Medicine Formulas
6. Post-Marketing Research of Proprietary Chinese Medicines
7. Core Facility Platform Services
(The content above was translated by AI.)
Founded Year
2018
Unified Business No.
50883914
Status
Active
Number of Employees
0
Total Paid-in
Capital
100,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Magus Biotechnology Corp. was spun off and established in 2019, making it the world's first contract research organization (CRO) primarily focused on botanical drug development. In 2023, the company passed the review by the Industrial Development Bureau of the Ministry of Economic Affairs and was certified under the domestic CRO key list.
Magus Biotechnology Corp. focuses on botanical drug development, providing one-stop services for botanical drug development. It possesses deep practical experience in botanical drug Chemistry, Manufacturing, and Controls (CMC), efficacy validation through animal and cell testing, and IND submissions. Furthermore, multiple botanical drugs have successfully obtained IND clearance.
The services of Magus Biotechnology Corp. cover a wide range, meeting various customer needs throughout the botanical drug development process and providing the highest quality integrated services. These include project evaluation, CMC and system integration for pre-IND R&D platforms, and the establishment and consulting services for raw material GACP platforms. Currently, the company is also dedicated to developing services in the fields of Chinese medicine new drugs (classical formulas), post-market re-evaluation, and Chinese medicinal herb cultivation.
(The content above was translated by AI.)
Magus Biotechnology Corp. focuses on botanical drug development, providing one-stop services for botanical drug development. It possesses deep practical experience in botanical drug Chemistry, Manufacturing, and Controls (CMC), efficacy validation through animal and cell testing, and IND submissions. Furthermore, multiple botanical drugs have successfully obtained IND clearance.
The services of Magus Biotechnology Corp. cover a wide range, meeting various customer needs throughout the botanical drug development process and providing the highest quality integrated services. These include project evaluation, CMC and system integration for pre-IND R&D platforms, and the establishment and consulting services for raw material GACP platforms. Currently, the company is also dedicated to developing services in the fields of Chinese medicine new drugs (classical formulas), post-market re-evaluation, and Chinese medicinal herb cultivation.
(The content above was translated by AI.)
